AAAAAA
Results: 1-25/54
Authors:
HARTUNG HP
VANDERMECHE FGA
POLLARD JD
Citation: Hp. Hartung et al., GUILLAIN-BARRE-SYNDROME, CIDP AND OTHER CHRONIC IMMUNE-MEDIATED NEUROPATHIES, Current opinion in neurology, 11(5), 1998, pp. 497-513
Authors:
JONGEN JLM
VANDOORN PA
VANDERMECHE FGA
Citation: Jlm. Jongen et al., HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR MYASTHENIA-GRAVIS, Journal of neurology, 245(1), 1998, pp. 26-31
Authors:
TERBRUGGEN JP
VANDERMECHE FGA
DEJAGER AEJ
POLMAN CH
Citation: Jp. Terbruggen et al., OPHTHALMOPLEGIC AND LOWER CRANIAL NERVE VARIANTS MERGE INTO EACH OTHER AND INTO CLASSICAL GUILLAIN-BARRE-SYNDROME, Muscle & nerve, 21(2), 1998, pp. 239-242
Authors:
JACOBS BC
ROTHBARTH PH
VANDERMECHE FGA
HERBRINK P
SCHMITZ PIM
DEKLERK MA
VANDOORN PA
Citation: Bc. Jacobs et al., THE SPECTRUM OF ANTECEDENT INFECTIONS IN GUILLAIN-BARRE-SYNDROME - A CASE-CONTROL STUDY, Neurology, 51(4), 1998, pp. 1110-1115
Authors:
MARTINA ISJ
VANKONINGSVELD R
SCHMITZ PIM
VANDERMECHE FGA
VANDOORN PA
Citation: Isj. Martina et al., MEASURING VIBRATION THRESHOLD WITH A GRADUATED TUNING FORK IN NORMAL AGING AND IN PATIENTS WITH POLYNEUROPATHY, Journal of Neurology, Neurosurgery and Psychiatry, 65(5), 1998, pp. 743-747
Authors:
VISSER LH
VANDERMECHE FGA
MEULSTEE J
VANDOORN PA
Citation: Lh. Visser et al., RISK-FACTORS FOR TREATMENT RELATED CLINICAL FLUCTUATIONS IN GUILLAIN-BARRE-SYNDROME, Journal of Neurology, Neurosurgery and Psychiatry, 64(2), 1998, pp. 242-244
Authors:
DEBOER JB
BULJEVAC D
VERMEULEN HG
VANDERMECHE FGA
PASSCHIER J
Citation: Jb. Deboer et al., THE IMPACT OF RELAPSES ON THE HEALTH-RELATED QUALITY-OF-LIFE OF PATIENTS WITH RELAPSE-REMITTING MULTIPLE-SCLEROSIS, Quality of life research, 6(7-8), 1997, pp. 76-76
Authors:
BOOT H
POUBLON RML
VANWEGEN R
BOGAARD JM
SCHMITZ PIM
GINAI AZ
VANDERMECHE FGA
Citation: H. Boot et al., OVULOPALATOPHARYNGOPLASTY FOR THE OBSTRUCTIVE SLEEP-APNEA SYNDROME - VALUE OF POLYSOMNOGRAPHY, MUELLER MANEUVER AND CEPHALOMETRY IN PREDICTING SURGICAL OUTCOME, Clinical otolaryngology and allied sciences, 22(6), 1997, pp. 504-510
Authors:
VANDERMECHE FGA
Citation: Fga. Vandermeche, CLINICAL-FEATURES AND TREATMENT OPTIONS, Acta neurologica belgica, 97(4), 1997, pp. 265-266
Authors:
JACOBS BC
ENDTZ HP
VANDERMECHE FGA
HAZENBERG MP
DEKLERK MA
VANDOORN PA
Citation: Bc. Jacobs et al., HUMORAL IMMUNE-RESPONSE AGAINST CAMPYLOBACTER-JEJUNI LIPOPOLYSACCHARIDES IN GUILLAIN-BARRE AND MILLER-FISHER-SYNDROME, Journal of neuroimmunology, 79(1), 1997, pp. 62-68
Authors:
JACOBS BC
MEULSTEE J
VANDOORN PA
VANDERMECHE FGA
Citation: Bc. Jacobs et al., ELECTRODIAGNOSTIC FINDINGS RELATED TO ANTI-GM1 AND ANTI-GQ1B ANTIBODIES IN GUILLAIN-BARRE-SYNDROME, Muscle & nerve, 20(4), 1997, pp. 446-452
Authors:
VANDERMECHE FGA
VANDOORN PA
Citation: Fga. Vandermeche et Pa. Vandoorn, THE CURRENT PLACE OF HIGH-DOSE IMMUNOGLOBULINS IN THE TREATMENT OF NEUROMUSCULAR DISORDERS, Muscle & nerve, 20(2), 1997, pp. 136-147
Authors:
VISSER LH
ROTHBARTH PP
VANDERMECHE FGA
Citation: Lh. Visser et al., CYTOMEGALOVIRUS-INFECTION AND GUILLAIN-BARRE-SYNDROME - REPLY, Neurology, 49(5), 1997, pp. 1473-1473
Authors:
DERIJK MC
BRETELER MMB
VANDERMECHE FGA
HOFMAN A
Citation: Mc. Derijk et al., THE RISK OF PARKINSONS-DISEASE AMONG PERSONS WITH A FAMILY HISTORY OFPARKINSONS-DISEASE OR DEMENTIA - THE ROTTERDAM STUDY, Neurology, 48(3), 1997, pp. 42003-42003
Authors:
FLIPSE JP
STRAATHOF CSM
VANDERSTEEN J
VANLEEUWEN AF
VANDOORN PA
VANDERMECHE FGA
COLLEWIJN H
Citation: Jp. Flipse et al., BINOCULAR SACCADIC EYE-MOVEMENTS IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 148(1), 1997, pp. 53-65
Authors:
BERNSEN RAJAM
JACOBS HM
DEJAGER AEJ
VANDERMECHE FGA
Citation: Rajam. Bernsen et al., RESIDUAL HEALTH-STATUS AFTER GUILLAIN-BARRE-SYNDROME, Journal of Neurology, Neurosurgery and Psychiatry, 62(6), 1997, pp. 637-640
Authors:
JACOBS BC
VANDOORN PA
GROENEVELD JHM
TIOGILLEN AP
VANDERMECHE FGA
Citation: Bc. Jacobs et al., CYTOMEGALOVIRUS INFECTIONS AND ANTI-GM2 ANTIBODIES IN GUILLAIN-BARRE-SYNDROME, Journal of Neurology, Neurosurgery and Psychiatry, 62(6), 1997, pp. 641-643
Authors:
MEULSTEE J
DARBAS A
VANDOORN PA
VANBRIEMEN L
VANDERMECHE FGA
Citation: J. Meulstee et al., DECREASED ELECTRICAL EXCITABILITY OF PERIPHERAL-NERVES IN DEMYELINATING POLYNEUROPATHIES, Journal of Neurology, Neurosurgery and Psychiatry, 62(4), 1997, pp. 398-400
Authors:
VANDERMECHE FGA
VISSER LH
JACOBS BC
ENDTZ HP
MEULSTEE J
VANDOORN PA
Citation: Fga. Vandermeche et al., GUILLAIN-BARRE-SYNDROME - MULTIFACTORIAL MECHANISMS VERSUS DEFINED SUBGROUPS, The Journal of infectious diseases, 176, 1997, pp. 99-102
Authors:
JACOBS BC
HAZENBERG MP
VANDOORN PA
ENDTZ HP
VANDERMECHE FGA
Citation: Bc. Jacobs et al., CROSS-REACTIVE ANTIBODIES AGAINST GANGLIOSIDES AND CAMPYLOBACTER-JEJUNI LIPOPOLYSACCHARIDES IN PATIENTS WITH GUILLAIN-BARRE OR MILLER-FISHER-SYNDROME, The Journal of infectious diseases, 175(3), 1997, pp. 729-733
Authors:
VANDERMECHE FGA
VANDOORN PA
Citation: Fga. Vandermeche et Pa. Vandoorn, FUTURE-DEVELOPMENTS IN THE TREATMENT OF IMMUNE-MEDIATED POLYNEUROPATHIES, European neurology, 38(3), 1997, pp. 230-237
Authors:
DERIJK MC
BRETELER MMB
DENBREEIJEN JH
LAUNER LJ
GROBBEE DE
VANDERMECHE FGA
HOFMAN A
Citation: Mc. Derijk et al., DIETARY ANTIOXIDANTS AND PARKINSONS-DISEASE - THE ROTTERDAM STUDY, Archives of neurology, 54(6), 1997, pp. 762-765
Authors:
VISSER LH
SCHMITZ PIM
MEULSTEE J
VANDOORN PA
VANDERMECHE FGA
Citation: Lh. Visser et al., PREDICTORS OF OUTCOME OF THE GUILLAIN-BARRE-SYNDROME AFTER TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNE GLOBULINS OR PLASMA-EXCHANGE, Annals of neurology, 40(3), 1996, pp. 84-84
Authors:
JACOBS BC
VANDOORN PA
SCHMITZ PIM
TIOGILLEN AP
HERBRINK P
VISSER LH
HOOIJKAAS H
VANDERMECHE FGA
Citation: Bc. Jacobs et al., CAMPYLOBACTER-JEJUNI INFECTIONS AND ANTI-GM1 ANTIBODIES IN GUILLAIN-BARRE-SYNDROME, Annals of neurology, 40(2), 1996, pp. 181-187
Authors:
FLIPSE JP
STRAATHOF CSM
VANDERSTEEN J
VANDOORN PA
VANDERMECHE FGA
COLLEWIJN H
Citation: Jp. Flipse et al., BINOCULAR SACCADIC ACCELERATION IN MULTIPLE-SCLEROSIS, Neuro-ophthalmology, 16(1), 1996, pp. 43-46